Interventional • Organizational benefit

MINERVA

Organizational benefit

80

Patients enrolled in the program

1

Participating center(s) across the study

Study description

A French prospective, randomized, open-label, single-centric study to assess the effectiveness of standard of care with Cureety, compared to standard of care alone, to reduce the duration and numbers of telephone calls during the first 4 months of oral or intravenous treatment.

Key results

The average number of calls per patient over 4 months of follow-up decreased from 5.6 to 1.9 with Cureety (p<0.0001)
The average duration of calls per patient over 4 months decreased from 28.3 to 12.1 minutes (p=0.0018)
The average duration of stay for hospitalized patients decreased from 39.3 to 15.3 days (p=0.02)

Research collaboration

Discuss this study with our research team

Questions about methodology, results, or potential collaborations — our team is available to engage with researchers, clinicians and life sciences partners.